Cargando…
Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
INTRODUCTION: Tricyclic antidepressants (TCAs) have an important role in pharmacotherapy of Major Depressive Disorder (MDD). TCA dosing is aimed at achieving a concentration in the therapeutic window. Due to inter-individual differences in activity of Cytochrome P450 (CYP) 2D6 and 2C19, (enzymes inv...
Autores principales: | Ter Hark, S., Vos, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596683/ http://dx.doi.org/10.1192/j.eurpsy.2023.275 |
Ejemplares similares
-
Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial
por: Vos, Cornelis F., et al.
Publicado: (2023) -
Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
por: Vos, Cornelis F., et al.
Publicado: (2021) -
Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter?
por: Sarker, Subhodeep, et al.
Publicado: (2008) -
Insights from pharmacogenetic studies of antidepressants
por: Mandelli, Laura
Publicado: (2010) -
Evaluation of Pharmaceutical Products of St. John’s Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial
por: Pakseresht, Sirus, et al.
Publicado: (2012)